Close Menu

NEW YORK – Autoimmune disease testing firm Exagen said after the close of the market on Tuesday that its third quarter revenues increased 4 percent year over year.

For the three months ended Sept. 30, the San Diego-based company reported revenues of $10.8 million compared to $10.4 million a year ago, beating the analysts' average estimate for revenues of $8.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.